Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulised intraperitoneal ropivacaine (NILA) for pain prevention after laparoscopic surgery
2009-015236-15Phase 4Completed
- Sponsor
- National University of Ireland
- Start
- Oct 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Nebulised intraperitoneal ropivacaine with Nebulised intraperitoneal placebo (2 arms). Primary endpoints: Postoperative shoulder tip pain at 6 hours, Postoperative shoulder tip pain at 12 hours and 2 more. Started Oct 2009; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2009-015236-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015236-15.